Any thoughts on whether the following should be considered a hint?
We are encouraged in the development of our anti-cancer drug Kevetrin by the FDA’s willingness to incentivize the regulatory processes for hard-to-treat diseases like ovarian cancer.
When mathematics and data are used in prediction we call this an 'educated guess'.
So, for those that might think I am daydreaming at $800 CTIX, please at least agree to call it 'educated daydreaming'.
AI
